Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade
Authors
Keywords
NK cells, Platelet activation, Platelets, Melanoma cells, Melanomas, Flow cytometry, Immune evasion, Enzyme-linked immunoassays
Journal
PLoS One
Volume 14, Issue 3, Pages e0211538
Publisher
Public Library of Science (PLoS)
Online
2019-03-26
DOI
10.1371/journal.pone.0211538
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
- (2017) Stefanie Maurer et al. OncoImmunology
- Metastasis: new functional implications of platelets and megakaryocytes
- (2016) Raphael Leblanc et al. BLOOD
- Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
- (2016) Joseph A. Fraietta et al. BLOOD
- Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors
- (2015) Andrea Gras Navarro et al. Frontiers in Immunology
- TIGIT and CD226: Tipping the Balance between Costimulatory and Coinhibitory Molecules to Augment the Cancer Immunotherapy Toolkit
- (2014) Kristen E. Pauken et al. CANCER CELL
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- Living in shear: platelets protect cancer cells from shear induced damage
- (2014) Karl Egan et al. CLINICAL & EXPERIMENTAL METASTASIS
- Inhibition of HSP90 by AT13387 Delays the Emergence of Resistance to BRAF Inhibitors and Overcomes Resistance to Dual BRAF and MEK Inhibition in Melanoma Models
- (2014) T. Smyth et al. MOLECULAR CANCER THERAPEUTICS
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
- (2014) Christopher J Chan et al. NATURE IMMUNOLOGY
- Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
- (2013) Maria Ascierto et al. Journal of Translational Medicine
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma
- (2012) Jian-Jun Li et al. Chinese Journal of Cancer
- Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
- (2011) Tuanjie Li et al. CANCER LETTERS
- Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
- (2011) T. Placke et al. CANCER RESEARCH
- Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells
- (2011) Karl Egan et al. PLoS One
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Platelet-Derived Transforming Growth Factor- Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
- (2009) H.-G. Kopp et al. CANCER RESEARCH
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started